COMPARATIVE STUDY OF ETHOSOMES AND PHARMACOSOMES AS A PROMISING APPROACH FOR IMPROVING DAPSONE AND CLOXACILLINE TRANSDERMAL ANTI-LEPROTIC ACTIVITY: IN VITRO AND IN VIVO STUDIES
DOI:
https://doi.org/10.22159/ijap.2026v18i2.57081Keywords:
Vesicles, Transdermal delivery, Ethosomal gel, Encapsulation studies, Drug diffuse study, StabilityAbstract
Objective: This study aimed to develop and evaluate a vesicular gel system for the topical delivery of dapsone and cloxacillin with the goal of enhancing drug permeation, sustaining release within the skin, and improving wound healing efficacy.
Methods: Gel were prepared and characterized for particle size, (PDI) Polydispersity index, zeta potential, and encapsulation efficiency. Optimized formulations F3 and P5 were further subjected to (FTIR) Fourier transform infrared spectroscopy, (SEM) Scanning electron microscopy, and (TEM) Transmission electron microscopy analyses to confirm FTIR and vesicle morphology. In vitro drug release of G3 and G5, skin irritation testing, stability studies, and in vivo wound healing evaluations were performed.
Results: F3 and P5 showed favorable Nano scale vesicle characteristics (116.3 nm and 110.6 nm; PDI: 0.32 and 0.36; zeta potential: –21.7 mV and –30.6 mV; encapsulation efficiency: 71.91% and 73.95%). The gels G3 and G5 demonstrated desirable physicochemical properties (pH ~7.0, high drug content of 76.88% and 83.54%, viscosity 45.223 cps and 40.154 cps, and superior spreadability). In vitro release studies confirmed biphasic sustained release, with G3 showing the highest cumulative release (88.68% over 24 h). Stability studies indicated no changes in physicochemical properties after 3 mo. Skin irritation tests confirmed biocompatibility, and in vivo experiments demonstrated superior wound healing with ethosomal gels, particularly G3, as evidenced by morphological and histological studies.
Conclusion: The ethosomal gel system, especially G3, offers significant potential as a topical carrier for dapsone and cloxacilline, with enhanced penetration, sustained release, stability, safety, and superior wound healing efficacy compared to conventional formulations.
References
1. Jain S, Jain P, Umamaheshwari RB, Jain NK. Transfersomes a novel vesicular carrier for enhanced transdermal delivery: development, characterization and performance evaluation. Drug Dev Ind Pharm. 2003;29(9):1013-26. doi: 10.1081/DDC-120025458, PMID 14606665.
2. Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm. 2003;258(1-2):141-51. doi: 10.1016/s0378-5173(03)00183-2, PMID 12753761.
3. Squillante E. Optimization of in vitro nifedipine penetration enhancement through hairless mouse skin. International Journal of Pharmaceutics. 1998;169(2):143-54. doi: 10.1016/S0378-5173(98)00110-0.
4. Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta. 1992 Feb;1104(1):226-32. doi: 10.1016/0005-2736(92)90154-e, PMID 1550849.
5. Cevc G, Gebauer D, Stieber J, Schatzlein A, Blume G. Ultraflexible vesicles, transferosomes have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta. 1998;1368(2):201-15. doi: 10.1016/s0005-2736(97)00177-6, PMID 9459598.
6. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13(1):238-52. doi: 10.1016/s0022-2836(65)80093-6, PMID 5859039.
7. Witika BA, Mweetwa LL, Tshiamo KO, Edler K, Matafwali SK, Ntemi PV. Vesicular drug delivery for the treatment of topical disorders: current and future perspectives. J Pharm Pharmacol. 2021;73(11):1427-41. doi: 10.1093/jpp/rgab082, PMID 34132342.
8. Molinelli E, Paolinelli M, Campanati A, Brisigotti V, Offidani A. Metabolic pharmacokinetic and toxicological issues surrounding Dapsonesone. Expert Opin Drug Metab Toxicol. 2019 Apr;15(5):367-79. doi: 10.1080/17425255.2019.1600670, PMID 30943794.
9. Goulart IM, Arbex GL, Carneiro MH, Rodrigues MS, Gadia R. Efeitos adversos da poliquimioterapia em pacientes com hanseniase: um levantamento de cinco anos em um Centro de Saude da Universidade Federal de Uberlandia. Rev Soc Bras Med Trop. 2002 Oct;35(5):453-60. doi: 10.1590/S0037-86822002000500005, PMID 12621663.
10. Barry BW. Mode of action of penetration enhancers in human skin. J Control Release. 1987;6(1):85-97. doi: 10.1016/0168-3659(87)90066-6.
11. Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst. 2009;26(6):523-80. doi: 10.1615/CritRevTherDrugCarrierSyst.v26.i6.10, PMID 20402623.
12. Nasr AM, Moftah F, Abourehab MAS, Gad S. Design formulation and characterization of valsartan nanoethosomes for improving their bioavailability. Pharmaceutics. 2022 Oct;14(11):2268. doi: 10.3390/pharmaceutics14112268, PMID 36365087.
13. Garg HAA, Sheoran R, Pawar N, Sanjeev, Rahul. Formulation and evaluation of miconazole pharmacosome by using solvent evaporation method to enhance solubility of miconazole. Int J Membr Sci Technol. 2023;10(4):2362-73. doi: 10.15379/ijmst.v10i3.3364.
14. Naseeb Basha Shaik SD. Mortha lakshmi pkand lathakukati formulation and evaluation of tizanidine hydrochloride-loaded ethosomes for transdermal delivery. J Pharm Sci Res. 2020 Sep;12(11):1400-10. doi: 10.1016/j.molliq.2024.125111.
15. Nimisha ZF, Kaur CD. Formulation and performance of Berberis aristata extract-loaded ethosomal gel. Asian J Pharm. 2017 Sep;11(3):176-83. doi: 10.22377/ajp.v11i03.1401.
16. Saraswathi TS, Roshini R, Damodharan N, Mothilal M, Janani SK. Development of lipid-based vesicles of terbinafine gel for skin delivery by 32 full factorial design. Int J App Pharm. 2024 Jul;16(4):231-43. doi: 10.22159/ijap.2024v16i4.50460.
17. Anju K, Priya S, Sandeep DS, Nayak P, Kumar P, Kumar A, Lobo CL, Krithi SP. Formulation and optimization of zaltoprofen-loaded ethosomal gel by using 2³ full factorial designs. J Pharm Res Int. 2021;33(24B):30-44. doi: 10.9734/jpri/2021/v33i24B31439.
18. Tiwari R, Tiwari G, Wal A, Gupta C. Liposomal delivery of 5 fluorouracil and tretinoin: an aspect of topical treatment of skin warts. Ars Pharm. 2019 May;60(3):139-46. doi: 10.30827/ars.v60i3.7966.
19. Ramkanth S, Madhusudhana Chetty C, Sudhakar Y, Thiruvengadarajan VS, Anitha P, Gopinath C. Development characterization and in vivo evaluation of proniosomal based transdermal delivery system of atenolol. Future J Pharm Sci. 2018;4(1):80–7. doi: 10.1016/j.fjps.2017.10.003.
20. Halagali P, Wannur VI, Patil AK, Torgal VD, Naik SM, Marennavar SA. Formulation and evaluation of quercetin ethosomal hydrogel for topical delivery system. Int J Pharm Investigation. 2024 Jul;14(3):749-58. doi: 10.5530/ijpi.14.3.84.
21. Tiwari A, Bag P, Sarkar M, Chawla V, Chawla PA. Formulation validation and evaluation studies on metaxalone and diclofenac potassium topical gel. Environ Anal Health Toxicol. 2021;36(1):e2021001. doi: 10.5620/eaht.2021001, PMID 33499562.
22. Andleeb M, Shoaib Khan HM, Daniyal M. Development, characterization and stability evaluation of topical gel loaded with ethosomes containing Achillea millefolium L. extract. Front Pharmacol. 2021;12:603227. doi: 10.3389/fphar.2021.603227, PMID 33912036.
23. Tiwari A, Bag P, Sarkar M, Chawla V, Chawla PA. Formulation validation and evaluation studies on metaxalone and diclofenac potassium topical gel. Environ Anal Health Toxicol. 2021;36(1):e2021001. doi: 10.5620/eaht.2021001, PMID 33499562.
24. Priya S, Shridhar P, Shekhara K, Shenthar S, Kudva SK. Tolnaftate-loaded ethosomal gel for topical delivery: formulation and in vitro evaluation. J Health Allied Sci. 2024 Jun;15(1):26-31. doi: 10.1055/s-0044-1787293.
25. Iizhar SA, Syed IA, Satar R, Ansari SA. In vitro assessment of pharmaceutical potential of ethosomes entrapped with terbinafine hydrochloride. J Adv Res. 2016;7(3):453-61. doi: 10.1016/j.jare.2016.03.003, PMID 27222750.
26. Liu X, Liu H, Liu J, He Z, Ding C, Huang G. Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo. Int J Nanomedicine. 2011 Jan;6:241-7. doi: 10.2147/IJN.S16044, PMID 21499422.
27. El-Hashemy HA. Design formulation and optimization of topical ethosomes using full factorial design: in vitro and ex-vivo characterization. J Liposome Res. 2022 Mar;32(1):74-82. doi: 10.1080/08982104.2021.1955925, PMID 34697998.
28. Wang J, Li Z, Sun F, Tang S, Zhang S, LV P. Evaluation of dermal irritation and skin sensitization due to vitacoxib. Toxicol Rep. 2017;4:287-90. doi: 10.1016/j.toxrep.2017.06.003, PMID 28959651.
29. Pankajnainwal DR. Perform skin irritation study of the developed formulation. Natural Volatiles & Essential Oils. 2020 Jan;7(1):86-95. doi: 10.52783/nveo.5451.
30. Jung H, Seo W, Jeong T, Kang HW, Kim S. A study on the skin irritation toxicity test of processed sulfur in new zealand white rabbit. J Pharmacopuncture. 2022 Mar;25(1):46-51. doi: 10.3831/KPI.2022.25.1.46, PMID 35371586.
31. Naves Mde M, Ribeiro FA, Patrocinio LG, Patrocinio JA, Fleury RN, Goulart IM. Bacterial load in the nose and its correlation to the immune response in leprosy patients. Lepr Rev. 2013 Mar;84(1):85-91. doi: 10.47276/lr.84.1.85, PMID 23741885.
32. Vishwanath SS, Rajput V, Rajput D. Nitin wathore a study of clinico-histopathological correlation in leprosy IP archives of cytology and histopathology research. 2022 Nov;7(3):164-70. doi: 10.18231/j.achr.2022.036.
33. Chandira RM, Pethappachetty P, Chandiran G, Samy DA. Formulation and evaluation of nanosponges of an antileprosy drug: topical application. Asian J Biol Life Sci. 2022 Aug;11(2):554-63. doi: 10.5530/ajbls.2022.11.75.
34. Nayak D, Mohanta YK, Rauta PR, Chakrabartty I, Saravanan M. Ethosomes for dermal and transdermal drug delivery systems. In: Barabadi H, Mostafavi E, Saravanan M, editors. Pharmaceutical nanobiotechnology for targeted therapy. Cham: Springer International Publishing; 2022. p. 313-36. doi: 10.1007/978-3-031-12658-1_11.
35. Moideen Muthu JM, Khan BA, Rajendran V, El-Sherbiny M, Othman G, Ahmed Hussamuldin AB, Al-Serwi RH. Polymeric ethosomal gel loaded with nimodipine: optimisation pharmacokinetic and histopathological analysis. Saudi Pharm J. 2022;30(11):1603–11. doi: 10.1016/j.jsps.2022.09.003.
36. Zaid Alkilani A, Hamed R, Abdo H, Swellmeen L, Basheer HA, Wahdan W. Formulation and evaluation of azithromycin-loaded niosomal gel: optimization in vitro studies rheological characterization and cytotoxicity study. ACS omega. 2022;7(44):39782-93. doi: 10.1021/acsomega.2c03762, PMID 36385887.
37. Ponduri TK, Guntupalli C, Jeganathan B, Malothu N. Impact of ligand conjugation of physicochemical attributes of polymeric nanoparticles of atypical antipsychotic drug for nose-to-brain delivery. Int J App Pharm. 2024 Nov;16(6):38-47. doi: 10.22159/ijap.2024v16i6.52003.
38. Jadhav SP, Dhakad PK, Gupta T, Gilhotra R. Formulation development and evaluation of paliperidone nanosuspension for solubility enhancement. Int J App Pharm. 2024 May;16(4):173-81. doi: 10.22159/ijap.2024v16i4.51218.
Published
How to Cite
Issue
Section
Copyright (c) 2026 priyanka maurya
This work is licensed under a Creative Commons Attribution 4.0 International License.